HYRTAZ Trademark

Trademark Overview


On Monday, February 1, 2016, a trademark application was filed for HYRTAZ with the United States Patent and Trademark Office. The USPTO has given the HYRTAZ trademark a serial number of 86892639. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 24, 2023. This trademark is owned by Glaxo Group Limited. The HYRTAZ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Vaccines; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
hyrtaz

General Information


Serial Number86892639
Word MarkHYRTAZ
Filing DateMonday, February 1, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 24, 2023
Registration Number5040373
Registration DateTuesday, September 13, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 28, 2016

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Vaccines; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 24, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Trademark Events


Event DateEvent Description
Friday, March 24, 2023CANCELLED SEC. 8 (6-YR)
Tuesday, November 8, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 8, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, September 13, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, September 13, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, June 28, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 28, 2016PUBLISHED FOR OPPOSITION
Wednesday, June 8, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 20, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 17, 2016ASSIGNED TO EXAMINER
Thursday, February 4, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 4, 2016NEW APPLICATION ENTERED